Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: Overt and subclinical hypothyroidism

Journal of Endocrinological Investigation

Volumn 21, Issue 4, 1998, Pages 219-225

  Vantyghem, M C ^a,c   Ghulam, A ^b   Hober, C ^a   D'Herbomez M ^c   Racadot, A ^b   Boersma, A ^b   Lefebvre, J ^a  

^a Serv d'Endocrinol Maladies M   (France)

^b Laboratoire d'Endocrinologie   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

11 hydroxysteroid dehydrogenase; Subclinical hypothyroidism; Urinary cortisol metabolites

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; THYROID HORMONE; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME DEFICIENCY; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NATRIURESIS; SODIUM EXCRETION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

EID: 0031806836     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347306     Document Type: Article

References (30)

1. Schaaf L., Pohl T., Schmidt R., Vardali I., Teuber J., Schlote-Sauter B., Nowotny B., Schiebeler H., Zober A., Usadel K.H. Screening for thyroid disorders in a working population. Clin. Invest. 71: 126, 1993.
2. Bemben D.A., Winn P., Hamm R.M., Morgan L., Davis A., Barton E. Thyroid disease in the elderly. Part 1. Prevalence of undiagnosed hypothyroidism. J. Fam. Pract. 38: 577, 1994.
3. de Groot L.J., Mayor G. Admisssion screening by thyroid function tests in an acute general care teaching hospital. Am. J. Med. 93: 558, 1992.
4. Staub J.J., Althaus B.U., Engler H., Ryff A.S., Trabucco P., Marquardt K., Burckhardt D., Girard J., Weintraub B.D. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin and thyroid reserve, and metabolic impact on peripheral target tissues. Am. J. Med. 92: 631, 1992.
5. Refetoff S. Thyroid function tests and effects of drugs on thyroid function. In: De Groot L.J. (Ed) Endocrinology. WB Saunders, Philadelphia, 1988, p. 590.
6. Peterson R.E. The influence of thyroid hormone on hydrocortisone production and metabolism. J. Clin. Invest. 37: 736, 1958.
7. Hellman L., Bradlow H.L., Zumoff B., Gallagher T.F. The influence of thyroid hormone on hydrocortisone production and metabolism. J. Clin. Endocrinol. Metab. 27: 1231, 1961.
8. Yamagi T., Motohashi K., Murakawa S., Ibayashi H. Urinary excretion of 6 beta hydroxycortisol in states of altered thyroid function. J. Clin. Endocrinol. Metab. 29: 801, 1969.
9. Linquette M., Lefebvre J., Racadot A., Cappoen J.P., Fontaine-Delort S. Taux de production et concentration plasmatique moyenne du cortisol dans l'hyperthyroïdie. Ann. Endocrinol. (Paris) 37: 331, 1976.
10. Ichikawa Y., Yoshida K., Kawagoe M., Saito E., Abe Y., Arikawa A., Homma M. Altered equilibrium between cortisol and cortisone in plasma in thyroid dysfunction and inflammatory diseases. Metabolism 26: 989, 1977.
11. Edwards C.R. Lessons from licorice. N. Engl. J. Med. 325: 1242, 1991.
12. Stewart P.M. 11 β-hydroxysteroid dehydrogenase: implication for clinical medicine. Clin. Endocrinol. (Oxf.) 44: 493, 1996.
13. Seckl J.R. 11 β-hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur. J. Clin. Invest. 23: 589, 1993.
14. Taniyama M., Homma K., Ban Y. Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: application for diagnosis of resistance to thyroid hormone. Thyroid 3: 229, 1993.
15. Shackleton C.H., Honour J.W. Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neonatal infants and children with abnormal steroid synthesis. Clin. Chim. Acta 69: 267, 1976.
16. Pallas D., Koutras D.A., Adamopoulos P., Marafelia P., Souvatzoglou A., Piperingos G., Moulopoulos S.D. Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients : does it mean occult hypothyrodism. J. Endocrinol. Invest. 74: 743, 1991.
17. Miura S., Litaka M., Yoshimura H., Kitahama S., Fukasawa N., Kawakami Y., Sakurai S., Urabe M., Sakatsume Y., Ito K. Disturbed lipid metabolism in patients with subclinical hypothyroidism : effect of L-thyroxine therapy. Intern. Med. 33: 413, 1994.
18. Franklyn J.A., Daykin J., Betteridge J., Hughes E.A., Holder R., Jones S.R., Sheppard M.C. Thyroxine replacement therapy and circulating lipid concentrations. Clin. Endocrinol. (Oxf) 38: 453, 1993.
19. Bogner U., Arntz H.R., Peters H., Schleusener H. Subclinical hypothyroidism and hyperlipoproteinaemia: Indiscriminate L-thyroxine treatment not justified. Acta Endocrinol. (Copenh.) 128: 202, 1993.
20. Bing R.F, Briggs R.S., Burden A.C., Russel G.I., Swales J.D., Thurston H. Reversible hypertension and hypothyroidism. Clin. Endocrinol. (Oxf) 13: 339, 1980.
21. Streeten D.H.P., Anderson G.H., Howland T., Chiang R., Smulyan H. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11: 78, 1988.
22. Cushing G.W. Subclinical hypothyroidism: Understanding is the key to decision making. Postgrad. Med. 94: 95, 1993.
23. Laryea E.A. Subclinical hypothyroidism: to treat or not to treat. Can. Fam. Physician 39: 1997, 1993.
24. Kabadi U.M. "Subclinical hypothyroidism", natural course of the syndrome during a prolonged follow-up study. Arch. Intern. Med. 153: 957, 1993.
25. Nikkila H., Tannin G.M., New M.I., Taylor N.F., Kalaitzoglou G., Monder C., White P.C. Defects in the HSD11 gene encoding 11 β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J. Clin. Endocrinol. Metab. 77: 687, 1993.
26. Mune T., Rogerson F.M., Nikkila H., Agarwal A.K., White P.C. Human hypertension caused by mutations in the kidney isozyme of 11 β-hydroxysteroid dehydrogenase. Nature Genetics 10: 394, 1995.
27. Stewart P.M., Corrie J.E., Shackleton C.H., Edwards C.R. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J. Clin. Invest. 82: 340, 1988.
28. Monder C., Shackleton C.H., Bradlow H.L, New M.I., Stoner E., Iohan F., Lakshmi V. The syndrome of apparent mineralocorticoid excess: its association with 11 β-dehydrogenase and 5 β-reductase deficiency and some consequences for corticosteroid metabolism. J. Clin. Endocrinol. Metab. 63: 550, 1986.
29. Ulick S., Tedde R., Wang J.Z. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 74: 593, 1992.
30. Farese R.V., Biglieri E.G., Shackleton C.H.L, Irony I., Gomez-Fontes R. Licorice-induced hypermineralocorticoidism. N. Engl. J. Med. 325: 1223, 1991.